TriSalus Life Sciences, Inc. Common Stock (TLSI) Stock Price, Quote & AI Analysis
Live TLSI stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for TriSalus Life Sciences, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for TriSalus Life Sciences, Inc. Common Stock (TLSI), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
TriSalus Life Sciences, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
TriSalus Life Sciences, Inc. Common Stock Overview
Company information
Company Overview
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
TriSalus Life Sciences, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...